Market Cap | 134.45K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -965k | Forward P/E | 0.00 | EPS next Y | - | 50D Avg Chg | -23.00% |
Sales | 2.36M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -34.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -88.00% |
Recommedations | - | Quick Ratio | 0.04 | Shares Outstanding | 18.28B | 52W Low Chg | 4,900.00% |
Insider Own | - | ROA | -36.25% | Shares Float | 10.12B | Beta | 63.15 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00005 |
Gross Margin | 51.38% | Profit Margin | -40.84% | Avg. Volume | 4,328,986 | Target Price | - |
Oper. Margin | -50.71% | Earnings Date | - | Volume | 1,056,499 | Change | 0.00% |
EVIO, Inc. provides analytical testing and consulting services for cannabis and hemp industry. The company was founded in 2014 and is based in Henderson, Nevada.